Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The gastrointestinal motility and secretory apparatus is a complex, integrated physiological system that governs the mechanical movement of food and the secretion of digestive enzymes, water, and electrolytes within the digestive tract (Furness, J. B., 2012, Annual Review of Physiology). It is primarily controlled by the enteric nervous system (ENS), often called the 'second brain', in coordination with the central nervous system and endocrine signals. This apparatus relies on a diverse array of molecular targets, including G protein-coupled receptors for serotonin and acetylcholine, as well as specialized ion channels like the cystic fibrosis transmembrane conductance regulator (CFTR) (Kiela, P. R., & Ghishan, F. K., 2016, Best Practice & Research Clinical Gastroenterology). Dysfunction in these processes can lead to significant clinical conditions such as gastroparesis, chronic constipation, and irritable bowel syndrome (Tack, J., et al., 2006, Gastroenterology). Therapeutic strategies often involve targeting specific components of this apparatus to restore normal transit times and fluid balance, though such interventions must be carefully managed to avoid systemic side effects or severe gastrointestinal distress (Camilleri, M., 2019, The Lancet Gastroenterology & Hepatology). Overall, the apparatus represents a critical interface between the body's internal environment and external nutrients, requiring precise regulation for metabolic homeostasis (Blackshaw, L. A., et al., 2007, Neurogastroenterology & Motility).
Pharmacological agents modulate this apparatus by acting as agonists or antagonists at specific receptors (e.g., 5-HT4, 5-HT3, mu-opioid, and muscarinic receptors) or by activating ion channels (e.g., CFTR, ClC-2) to regulate the contraction of smooth muscle and the transport of fluids and electrolytes across the intestinal epithelium (Camilleri, M., 2019, The Lancet Gastroenterology & Hepatology).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gastrointestinal motility and secretory apparatus.